The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastaticlung cancer.
In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for advanced stage or metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention.
new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC 18 years of age or older ECOG PS 0-2/Karnofsky 60-100 3 to 12 weeks into active cancer treatment
Exclusion Criteria:
unstable brain metastases cognitive or psychiatric condition for which participating would be inappropriate unable to speak and read English
